Novel interesting strategies using mesothelin CAR and a suicide strategy that induces apoptosis in cancer cells after binding via iCaspase9 release are ongoing in patients with pleural tumors [ClinicalTrials.gov identifiers: NCT02414269 and NCT02792114] and might represent an interesting strategy in EOC. This evidence concerns the gene MSLN and cancer.